Global Hereditary Angioedema Drug Market Professional Survey Report 2017

October 2017 | 105 pages | ID: GBAA0BB41B4PEN
QYResearch

Abstracts

This report studies Hereditary Angioedema Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Pharming Group NV
• Shire plc
• CSL Limited
• iBio Inc.
• BioCryst Pharmaceuticals, Inc.
• Ionis Pharmaceuticals, Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• By Product
• C1 Esterase Inhibitor
• Kallikrein Inhibitor
• Selective Bradykinin B2 Receptor Antagonist
• By Route of Administration
• Oral
• Intravenous
• Subcutaneous Injection

By Application, the market can be split into

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Hereditary Angioedema Drug Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF HEREDITARY ANGIOEDEMA DRUG

1.1 Definition and Specifications of Hereditary Angioedema Drug
  1.1.1 Definition of Hereditary Angioedema Drug
  1.1.2 Specifications of Hereditary Angioedema Drug
1.2 Classification of Hereditary Angioedema Drug
  1.2.1 C1 Esterase Inhibitor
  1.2.2 Kallikrein Inhibitor
  1.2.3 Selective Bradykinin B2 Receptor Antagonist
1.3 Applications of Hereditary Angioedema Drug
  1.3.1 Retail Pharmacies
  1.3.2 Hospital Pharmacies
  1.3.3 Online Pharmacies
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF HEREDITARY ANGIOEDEMA DRUG

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hereditary Angioedema Drug
2.3 Manufacturing Process Analysis of Hereditary Angioedema Drug
2.4 Industry Chain Structure of Hereditary Angioedema Drug

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF HEREDITARY ANGIOEDEMA DRUG

3.1 Capacity and Commercial Production Date of Global Hereditary Angioedema Drug Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Hereditary Angioedema Drug Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Hereditary Angioedema Drug Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Hereditary Angioedema Drug Major Manufacturers in 2016

4 GLOBAL HEREDITARY ANGIOEDEMA DRUG OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Hereditary Angioedema Drug Capacity and Growth Rate Analysis
  4.2.2 2016 Hereditary Angioedema Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Hereditary Angioedema Drug Sales and Growth Rate Analysis
  4.3.2 2016 Hereditary Angioedema Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Hereditary Angioedema Drug Sales Price
  4.4.2 2016 Hereditary Angioedema Drug Sales Price Analysis (Company Segment)

5 HEREDITARY ANGIOEDEMA DRUG REGIONAL MARKET ANALYSIS

5.1 North America Hereditary Angioedema Drug Market Analysis
  5.1.1 North America Hereditary Angioedema Drug Market Overview
  5.1.2 North America 2012-2017E Hereditary Angioedema Drug Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Hereditary Angioedema Drug Sales Price Analysis
  5.1.4 North America 2016 Hereditary Angioedema Drug Market Share Analysis
5.2 China Hereditary Angioedema Drug Market Analysis
  5.2.1 China Hereditary Angioedema Drug Market Overview
  5.2.2 China 2012-2017E Hereditary Angioedema Drug Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Hereditary Angioedema Drug Sales Price Analysis
  5.2.4 China 2016 Hereditary Angioedema Drug Market Share Analysis
5.3 Europe Hereditary Angioedema Drug Market Analysis
  5.3.1 Europe Hereditary Angioedema Drug Market Overview
  5.3.2 Europe 2012-2017E Hereditary Angioedema Drug Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Hereditary Angioedema Drug Sales Price Analysis
  5.3.4 Europe 2016 Hereditary Angioedema Drug Market Share Analysis
5.4 Southeast Asia Hereditary Angioedema Drug Market Analysis
  5.4.1 Southeast Asia Hereditary Angioedema Drug Market Overview
  5.4.2 Southeast Asia 2012-2017E Hereditary Angioedema Drug Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Hereditary Angioedema Drug Sales Price Analysis
  5.4.4 Southeast Asia 2016 Hereditary Angioedema Drug Market Share Analysis
5.5 Japan Hereditary Angioedema Drug Market Analysis
  5.5.1 Japan Hereditary Angioedema Drug Market Overview
  5.5.2 Japan 2012-2017E Hereditary Angioedema Drug Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Hereditary Angioedema Drug Sales Price Analysis
  5.5.4 Japan 2016 Hereditary Angioedema Drug Market Share Analysis
5.6 India Hereditary Angioedema Drug Market Analysis
  5.6.1 India Hereditary Angioedema Drug Market Overview
  5.6.2 India 2012-2017E Hereditary Angioedema Drug Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Hereditary Angioedema Drug Sales Price Analysis
  5.6.4 India 2016 Hereditary Angioedema Drug Market Share Analysis

6 GLOBAL 2012-2017E HEREDITARY ANGIOEDEMA DRUG SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Hereditary Angioedema Drug Sales by Type
6.2 Different Types of Hereditary Angioedema Drug Product Interview Price Analysis
6.3 Different Types of Hereditary Angioedema Drug Product Driving Factors Analysis
  6.3.1 By Product of Hereditary Angioedema Drug Growth Driving Factor Analysis
  6.3.2 By Route of Administration of Hereditary Angioedema Drug Growth Driving Factor Analysis

7 GLOBAL 2012-2017E HEREDITARY ANGIOEDEMA DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Hereditary Angioedema Drug Consumption by Application
7.2 Different Application of Hereditary Angioedema Drug Product Interview Price Analysis
7.3 Different Application of Hereditary Angioedema Drug Product Driving Factors Analysis
  7.3.1 Retail Pharmacies of Hereditary Angioedema Drug Growth Driving Factor Analysis
  7.3.2 Hospital Pharmacies of Hereditary Angioedema Drug Growth Driving Factor Analysis
  7.3.3 Online Pharmacies of Hereditary Angioedema Drug Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF HEREDITARY ANGIOEDEMA DRUG

8.1 Pharming Group NV
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Pharming Group NV 2016 Hereditary Angioedema Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Pharming Group NV 2016 Hereditary Angioedema Drug Business Region Distribution Analysis
8.2 Shire plc
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Shire plc 2016 Hereditary Angioedema Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Shire plc 2016 Hereditary Angioedema Drug Business Region Distribution Analysis
8.3 CSL Limited
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 CSL Limited 2016 Hereditary Angioedema Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 CSL Limited 2016 Hereditary Angioedema Drug Business Region Distribution Analysis
8.4 iBio Inc.
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 iBio Inc. 2016 Hereditary Angioedema Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 iBio Inc. 2016 Hereditary Angioedema Drug Business Region Distribution Analysis
8.5 BioCryst Pharmaceuticals, Inc.
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 BioCryst Pharmaceuticals, Inc. 2016 Hereditary Angioedema Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 BioCryst Pharmaceuticals, Inc. 2016 Hereditary Angioedema Drug Business Region Distribution Analysis
8.6 Ionis Pharmaceuticals, Inc.
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Ionis Pharmaceuticals, Inc. 2016 Hereditary Angioedema Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Ionis Pharmaceuticals, Inc. 2016 Hereditary Angioedema Drug Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF HEREDITARY ANGIOEDEMA DRUG MARKET

9.1 Global Hereditary Angioedema Drug Market Trend Analysis
  9.1.1 Global 2017-2022 Hereditary Angioedema Drug Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Hereditary Angioedema Drug Sales Price Forecast
9.2 Hereditary Angioedema Drug Regional Market Trend
  9.2.1 North America 2017-2022 Hereditary Angioedema Drug Consumption Forecast
  9.2.2 China 2017-2022 Hereditary Angioedema Drug Consumption Forecast
  9.2.3 Europe 2017-2022 Hereditary Angioedema Drug Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Hereditary Angioedema Drug Consumption Forecast
  9.2.5 Japan 2017-2022 Hereditary Angioedema Drug Consumption Forecast
  9.2.6 India 2017-2022 Hereditary Angioedema Drug Consumption Forecast
9.3 Hereditary Angioedema Drug Market Trend (Product Type)
9.4 Hereditary Angioedema Drug Market Trend (Application)

10 HEREDITARY ANGIOEDEMA DRUG MARKETING TYPE ANALYSIS

10.1 Hereditary Angioedema Drug Regional Marketing Type Analysis
10.2 Hereditary Angioedema Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Hereditary Angioedema Drug by Region
10.4 Hereditary Angioedema Drug Supply Chain Analysis

11 CONSUMERS ANALYSIS OF HEREDITARY ANGIOEDEMA DRUG

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL HEREDITARY ANGIOEDEMA DRUG MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Hereditary Angioedema Drug
Table Product Specifications of Hereditary Angioedema Drug
Table Classification of Hereditary Angioedema Drug
Figure Global Production Market Share of Hereditary Angioedema Drug by Type in 2016
Figure C1 Esterase Inhibitor Picture
Table Major Manufacturers of C1 Esterase Inhibitor
Figure Kallikrein Inhibitor Picture
Table Major Manufacturers of Kallikrein Inhibitor
Figure Selective Bradykinin B2 Receptor Antagonist Picture
Table Major Manufacturers of Selective Bradykinin B2 Receptor Antagonist
Table Applications of Hereditary Angioedema Drug
Figure Global Consumption Volume Market Share of Hereditary Angioedema Drug by Application in 2016
Figure Retail Pharmacies Examples
Table Major Consumers in Retail Pharmacies
Figure Hospital Pharmacies Examples
Table Major Consumers in Hospital Pharmacies
Figure Online Pharmacies Examples
Table Major Consumers in Online Pharmacies
Figure Market Share of Hereditary Angioedema Drug by Regions
Figure North America Hereditary Angioedema Drug Market Size (Million USD) (2012-2022)
Figure China Hereditary Angioedema Drug Market Size (Million USD) (2012-2022)
Figure Europe Hereditary Angioedema Drug Market Size (Million USD) (2012-2022)
Figure Southeast Asia Hereditary Angioedema Drug Market Size (Million USD) (2012-2022)
Figure Japan Hereditary Angioedema Drug Market Size (Million USD) (2012-2022)
Figure India Hereditary Angioedema Drug Market Size (Million USD) (2012-2022)
Table Hereditary Angioedema Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hereditary Angioedema Drug in 2016
Figure Manufacturing Process Analysis of Hereditary Angioedema Drug
Figure Industry Chain Structure of Hereditary Angioedema Drug
Table Capacity and Commercial Production Date of Global Hereditary Angioedema Drug Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Hereditary Angioedema Drug Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Hereditary Angioedema Drug Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Hereditary Angioedema Drug Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Hereditary Angioedema Drug 2012-2017
Figure Global 2012-2017E Hereditary Angioedema Drug Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Hereditary Angioedema Drug Market Size (Value) and Growth Rate
Table 2012-2017E Global Hereditary Angioedema Drug Capacity and Growth Rate
Table 2016 Global Hereditary Angioedema Drug Capacity (MT) List (Company Segment)
Table 2012-2017E Global Hereditary Angioedema Drug Sales (MT) and Growth Rate
Table 2016 Global Hereditary Angioedema Drug Sales (MT) List (Company Segment)
Table 2012-2017E Global Hereditary Angioedema Drug Sales Price (USD/Kg)
Table 2016 Global Hereditary Angioedema Drug Sales Price (USD/Kg) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (MT) of Hereditary Angioedema Drug 2012-2017E
Figure North America 2012-2017E Hereditary Angioedema Drug Sales Price (USD/Kg)
Figure North America 2016 Hereditary Angioedema Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (MT) of Hereditary Angioedema Drug 2012-2017E
Figure China 2012-2017E Hereditary Angioedema Drug Sales Price (USD/Kg)
Figure China 2016 Hereditary Angioedema Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (MT) of Hereditary Angioedema Drug 2012-2017E
Figure Europe 2012-2017E Hereditary Angioedema Drug Sales Price (USD/Kg)
Figure Europe 2016 Hereditary Angioedema Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (MT) of Hereditary Angioedema Drug 2012-2017E
Figure Southeast Asia 2012-2017E Hereditary Angioedema Drug Sales Price (USD/Kg)
Figure Southeast Asia 2016 Hereditary Angioedema Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (MT) of Hereditary Angioedema Drug 2012-2017E
Figure Japan 2012-2017E Hereditary Angioedema Drug Sales Price (USD/Kg)
Figure Japan 2016 Hereditary Angioedema Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (MT) of Hereditary Angioedema Drug 2012-2017E
Figure India 2012-2017E Hereditary Angioedema Drug Sales Price (USD/Kg)
Figure India 2016 Hereditary Angioedema Drug Sales Market Share
Table Global 2012-2017E Hereditary Angioedema Drug Sales (MT) by Type
Table Different Types Hereditary Angioedema Drug Product Interview Price
Table Global 2012-2017E Hereditary Angioedema Drug Sales (MT) by Application
Table Different Application Hereditary Angioedema Drug Product Interview Price
Table Pharming Group NV Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pharming Group NV Hereditary Angioedema Drug Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2016 Pharming Group NV Hereditary Angioedema Drug Business Region Distribution
Table Shire plc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Shire plc Hereditary Angioedema Drug Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2016 Shire plc Hereditary Angioedema Drug Business Region Distribution
Table CSL Limited Information List
Table Product A Overview
Table Product B Overview
Table 2015 CSL Limited Hereditary Angioedema Drug Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2016 CSL Limited Hereditary Angioedema Drug Business Region Distribution
Table iBio Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 iBio Inc. Hereditary Angioedema Drug Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2016 iBio Inc. Hereditary Angioedema Drug Business Region Distribution
Table BioCryst Pharmaceuticals, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2016 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Business Region Distribution
Table Ionis Pharmaceuticals, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Revenue (Million USD), Sales (MT), Ex-factory Price (USD/Kg)
Figure 2016 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Business Region Distribution
Figure Global 2017-2022 Hereditary Angioedema Drug Market Size (MT) and Growth Rate Forecast
Figure Global 2017-2022 Hereditary Angioedema Drug Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Hereditary Angioedema Drug Sales Price (USD/Kg) Forecast
Figure North America 2017-2022 Hereditary Angioedema Drug Consumption Volume (MT) and Growth Rate Forecast
Figure China 2017-2022 Hereditary Angioedema Drug Consumption Volume (MT) and Growth Rate Forecast
Figure Europe 2017-2022 Hereditary Angioedema Drug Consumption Volume (MT) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Hereditary Angioedema Drug Consumption Volume (MT) and Growth Rate Forecast
Figure Japan 2017-2022 Hereditary Angioedema Drug Consumption Volume (MT) and Growth Rate Forecast
Figure India 2017-2022 Hereditary Angioedema Drug Consumption Volume (MT) and Growth Rate Forecast
Table Global Sales Volume (MT) of Hereditary Angioedema Drug by Type 2017-2022
Table Global Consumption Volume (MT) of Hereditary Angioedema Drug by Application 2017-2022
Table Traders or Distributors with Contact Information of Hereditary Angioedema Drug by Region